U.S. vaccine and immune globulin product shortages, 2001-15

Purpose Trends in shortages of vaccines and immune globulin products from 2001 through 2015 in the United States are described. - Methods Drug shortage data from January 2001 through December 2015 were obtained from the University of Utah Drug Information Service. Shortage data for vaccines and immu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Ziesenitz, Victoria C. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: November 8, 2017
In: AJHP
Year: 2017, Jahrgang: 74, Heft: 22, Pages: 1879-1886
ISSN:1535-2900
DOI:10.2146/ajhp170066
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.2146/ajhp170066
Verlag, Volltext: http://www.ajhp.org/content/74/22/1879
Volltext
Verfasserangaben:Victoria C. Ziesenitz, Maryann Mazer-Amirshahi, Mark S. Zocchi, Erin R. Fox and Larissa S. May

MARC

LEADER 00000caa a22000002c 4500
001 1580152872
003 DE-627
005 20230427065647.0
007 cr uuu---uuuuu
008 180817s2017 xx |||||o 00| ||eng c
024 7 |a 10.2146/ajhp170066  |2 doi 
035 |a (DE-627)1580152872 
035 |a (DE-576)510152872 
035 |a (DE-599)BSZ510152872 
035 |a (OCoLC)1341017180 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ziesenitz, Victoria C.  |d 1985-  |e VerfasserIn  |0 (DE-588)1036795640  |0 (DE-627)751696099  |0 (DE-576)386865132  |4 aut 
245 1 0 |a U.S. vaccine and immune globulin product shortages, 2001-15  |c Victoria C. Ziesenitz, Maryann Mazer-Amirshahi, Mark S. Zocchi, Erin R. Fox and Larissa S. May 
264 1 |c November 8, 2017 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.08.2018 
520 |a Purpose Trends in shortages of vaccines and immune globulin products from 2001 through 2015 in the United States are described. - Methods Drug shortage data from January 2001 through December 2015 were obtained from the University of Utah Drug Information Service. Shortage data for vaccines and immune globulins were analyzed, focusing on the type of product, reason for shortage, shortage duration, shortages requiring vaccine deferral, and whether the drug was a single-source product. Inclusion of the product into the pediatric vaccination schedule was also noted. - Results Of the 2,080 reported drug shortages, 59 (2.8%) were for vaccines and immune globulin products. Of those, 2 shortages (3%) remained active at the end of the study period. The median shortage duration was 16.8 months. The most common products on shortage were viral vaccines (58%), especially hepatitis A, hepatitis B, rabies, and varicella vaccines (4 shortages each). A vaccine deferral was required for 21 shortages (36%), and single-source products were on shortage 30 times (51%). The most common reason for shortage was manufacturing problems (51%), followed by supply-and-demand issues (7%). Thirty shortages (51%) were for products on the pediatric schedule, with a median duration of 21.7 months. - Conclusion Drug shortages of vaccines and immune globulin products accounted for only 2.8% of reported drug shortages within a 15-year period, but about half of these shortages involved products on the pediatric vaccination schedule, which may have significant public health implications. 
650 4 |a bacterial vaccines 
650 4 |a immunization 
650 4 |a immunoglobulins 
650 4 |a supply and distribution 
650 4 |a vaccines 
650 4 |a viral vaccines 
773 0 8 |i Enthalten in  |t AJHP  |d Oxford : Oxford University Press, 1995  |g 74(2017), 22, Seite 1879-1886  |h Online-Ressource  |w (DE-627)334290783  |w (DE-600)2057140-9  |w (DE-576)273867091  |x 1535-2900  |7 nnas  |a U.S. vaccine and immune globulin product shortages, 2001-15 
773 1 8 |g volume:74  |g year:2017  |g number:22  |g pages:1879-1886  |g extent:8  |a U.S. vaccine and immune globulin product shortages, 2001-15 
856 4 0 |u http://dx.doi.org/10.2146/ajhp170066  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://www.ajhp.org/content/74/22/1879  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180817 
993 |a Article 
994 |a 2017 
998 |g 1036795640  |a Ziesenitz, Victoria C.  |m 1036795640:Ziesenitz, Victoria C.  |d 910000  |d 910500  |e 910000PZ1036795640  |e 910500PZ1036795640  |k 0/910000/  |k 1/910000/910500/  |p 1  |x j 
999 |a KXP-PPN1580152872  |e 3022523580 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"family":"Ziesenitz","given":"Victoria C.","roleDisplay":"VerfasserIn","display":"Ziesenitz, Victoria C.","role":"aut"}],"title":[{"title":"U.S. vaccine and immune globulin product shortages, 2001-15","title_sort":"U.S. vaccine and immune globulin product shortages, 2001-15"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 17.08.2018"],"language":["eng"],"recId":"1580152872","name":{"displayForm":["Victoria C. Ziesenitz, Maryann Mazer-Amirshahi, Mark S. Zocchi, Erin R. Fox and Larissa S. May"]},"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"November 8, 2017"}],"id":{"eki":["1580152872"],"doi":["10.2146/ajhp170066"]},"physDesc":[{"extent":"8 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1535-2900"],"eki":["334290783"],"zdb":["2057140-9"]},"origin":[{"dateIssuedDisp":"1995-","dateIssuedKey":"1995","publisher":"Oxford University Press ; American Society of Health-System Pharmacists","publisherPlace":"Oxford ; Bethesda, MD"}],"part":{"pages":"1879-1886","issue":"22","year":"2017","extent":"8","volume":"74","text":"74(2017), 22, Seite 1879-1886"},"titleAlt":[{"title":"official journal of ASHP"}],"pubHistory":["52.1995 -"],"recId":"334290783","language":["eng"],"disp":"U.S. vaccine and immune globulin product shortages, 2001-15AJHP","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 20.12.2019"],"title":[{"title_sort":"AJHP","subtitle":"American journal of health system pharmacy","title":"AJHP"}]}]} 
SRT |a ZIESENITZVUSVACCINEA8201